IG
ROIV icon

ING Group’s Roivant Sciences ROIV Stock Holding History

ING Group’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20M Buy
564,600
+173,100
+44% +$5.12M 0.1% 165
2026
Q1 		$10.8M Sell
391,500
-196,900
-33% -$5.06M 0.07% 196
2025
Q4 		$12.8M Buy
+588,400
New +$11.6M 0.08% 168
2023
Q4 		– Sell
-1,831,700
Closed -$21.4M – 638
2023
Q3 		$21.4M Buy
+1,831,700
New +$20.7M 0.19% 105

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ING Group's ROIV Position: Q2 2026 in Review

ING Group increased its Roivant Sciences (ROIV) stake by 44% in Q2 2026, buying an estimated $5.12M and bringing the position to 564,600 shares worth $20M. The position accounts for 0.1% of the portfolio, ranked #165.

ING Group first reported a position in ROIV in Q3 2023 and has held it in 4 quarters since. The position peaked at $21.4M in Q3 2023. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • ING Group held 564,600 shares of Roivant Sciences worth $20M as of Q2 2026.
  • ING Group bought 173,100 Roivant Sciences shares in Q2 2026, an estimated $5.12M.
  • Roivant Sciences made up 0.1% of ING Group's portfolio in Q2 2026, its #165 holding.
  • ING Group first reported a position in Roivant Sciences in Q3 2023 and has held it in 4 quarters since.
  • ING Group's Roivant Sciences position peaked at $21.4M in Q3 2023.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.